UK markets close in 6 hours 29 minutes

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
9.32-0.01 (-0.11%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 18.49B
Enterprise value 17.55B
Trailing P/E 16.63
Forward P/E 24.81
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.27
Price/book (mrq)2.53
Enterprise value/revenue 5.95
Enterprise value/EBITDA 13.51

Trading information

Stock price history

Beta (5Y monthly) 0.21
52-week change 3-18.87%
S&P500 52-week change 326.94%
52-week high 312.73
52-week low 38.40
50-day moving average 310.16
200-day moving average 310.49

Share statistics

Avg vol (3-month) 328.21M
Avg vol (10-day) 319.61M
Shares outstanding 51.98B
Implied shares outstanding 62.01B
Float 81.16B
% held by insiders 131.76%
% held by institutions 120.21%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.25
Forward annual dividend yield 42.64%
Trailing annual dividend rate 30.25
Trailing annual dividend yield 32.68%
5-year average dividend yield 42.60
Payout ratio 443.86%
Dividend date 3N/A
Ex-dividend date 423 May 2024
Last split factor 21.2:1
Last split date 325 May 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 37.72%
Operating margin (ttm)36.35%

Management effectiveness

Return on assets (ttm)10.17%
Return on equity (ttm)15.91%

Income statement

Revenue (ttm)3B
Revenue per share (ttm)1.51
Quarterly revenue growth (yoy)-11.10%
Gross profit (ttm)N/A
EBITDA 1.41B
Net income avi to common (ttm)1.13B
Diluted EPS (ttm)0.56
Quarterly earnings growth (yoy)-14.30%

Balance sheet

Total cash (mrq)1.17B
Total cash per share (mrq)0.6
Total debt (mrq)230M
Total debt/equity (mrq)3.10%
Current ratio (mrq)6.66
Book value per share (mrq)3.81

Cash flow statement

Operating cash flow (ttm)858.42M
Levered free cash flow (ttm)255.48M